X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.55
Delayed Data
As of Mar 27
 +0.31 / +13.84%
Today’s Change
1.55
Today|||52-Week Range
5.04
+28.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-1.3M-1.2M-1.7M-3.7M
 
 
 
 
 
Depreciation42.0K93.6K135.9K313.9K
 
 
 
 
 
Total Other Cash Flow207.0K83.7K-135.9K1.4M
 
 
 
 
 
Funds From Operations-1.0M-1.0M-1.7M-2.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-273.0K281.9K-235.9K482.3K
 
 
 
 
 
Net Cash Flow - Operating Activities-735.0K-1.3M-1.5M-2.5M
 
 
 
 
 
 
InvestingIncrease In Investments-81.0K-8.0K-1.7M0.00
 
 
 
 
Decrease In Investments0.000.000.003.4M
 
 
Capital Expenditures-16.0K-12.0K-6.0K-84.2K
 
 
 
 
 
Fixed Asset Disposal0.000.00732.7K0.00
 
 
Other Investing - Uses-6.0K-1.4M-169.9K0.00
 
 
 
 
Other Investing - Sources0.0024.9K999.600.00
 
 
 
Net Cash Flow Investing-103.0K-1.4M-1.2M3.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.5M1.7M4.3M317.9K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.5M1.7M4.3M317.9K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash12.0K-3.0K5.0K37.1K
 
 
 
 
 
 
Net Change In Cash642.0K-936.3K1.6M1.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account